UK Musculoskeletal Translational Research Collaboration
The UK Musculoskeletal Translational Research Collaboration (UK MSK TRC) is a joint collaboration between the NIHR and Versus Arthritis, bringing together the Versus Arthritis investment in Experimental Arthritis and Osteoarthritis Treatment Centres with the relevant NIHR infrastructure with expertise in MSK.
The UK MSK TRC aligns investment in MSK translational research creating a UK-wide ambition and focus to drive cutting edge translational research in order to improve outcomes for patients. The UK MSK TRC also provides industry with streamlined access to world leading academic clinicians and scientists who have significant expertise in a wide range of inflammatory and rheumatoid conditions. The UK MSK TRC is made of globally recognised centres and continues to work towards the goal of being at the forefront of MSK experimental medicine.
The UK MSK TRC works collaboratively with all sectors of the health and care ecosystem including the life sciences industry, charities and other funders to further research in MSK disorders and to help develop new diagnostics and treatments.
Who is this for?
To be suitable for UK MSK TRC support, a project is expected to:
- involve one or more industry partners
- focus on a disease area recognised as a TRC area of expertise
- bring significant academic value and the opportunity for scientific leadership from the TRC
- be at an early stage to enable input and feedback on study design and adopt a collaborative approach to study design
- utilise experimental medicine approaches such as novel exploratory endpoints, biomarkers and stratification strategies
- have a trial management team or delegated CRO or academic clinical trial unit in place to ensure effective study delivery.
The UK MSK TRC experts will help you to shape your protocol, providing advice on study design. The UK MSK TRC can offer scientific advice when there is a clear intent to deliver the study through the Collaboration, they are not designed to act as stand-alone advisory boards.
If you already have a fully-developed protocol and are only looking for recruitment sites the NIHR Study Support Service will be able to help you.
The second call of Accelerating New Treatments Versus Arthritis is now open for applications. This call will support projects focused on mechanistic experimental/translational medicine studies in humans across the areas of prevention, diagnosis or treatment that are aimed at priming the next transitional step.
Applications should be focused on an unmet need, within or across the UK MSK TRC’s themes. Studies can employ novel design, exploratory endpoints, biomarkers, imaging, big data or profiling/stratification approaches.
The deadline for this call is 1 December 2021.
Benefits of working with the UK MSK TRC
The UK MSK TRC provide operational support, including a standard pre-approved non-disclosure agreement, contractual templates and a close working relationship with the NIHR Clinical Research Network for identification of sites.
The UK MSK TRC provides cutting-edge expertise in the development of exploratory protocols, biomarkers discovery, and an understanding of pathophysiology and disease mechanisms in a range of inflammatory and rheumatoid disorders, including:
- Connective Tissue Disorders
- Systemic lupus erythematosus
- Systemic sclerosisSjögren's syndrome
- Idiopathic inflammatory myositis
- ANCA-associated vasculitis
- Large vessel vasculitis
- Inflammatory Arthritis
- Rheumatoid Arthritis
- Ankylosing spondylitis
- Psoriatic arthritis
- Reactive arthritis
- Musculoskeletal Conditions
- Back and shoulder pain
- Crystal disease
- Metabolic bone disorders
- MSK injuries caused by acute traumatic events
- Other regional pain syndromes
- Cross cutting themes
- Life-Course approach
- Patient and Public Involvement and Engagement (PPIE)
- Experimental Medicine Platforms
The UK MSK TRC regularly reviews areas of unmet clinical need to determine emerging topics that could become a focus for the group.
The breadth of Musculoskeletal Translational Research Collaboration expertise in the UK
The location map shows the locations of some of the key NIHR Biomedical Research Centres based across the UK (listed below) which are part of this Partnership.
List of UK MSK TRC partner organisations and lead academics
- Professor Maya Buch - Chair
NIHR Manchester Biomedical Research Centre.
- Prof. Stefan Siebert - Deputy Chair
RACE - Research into Inflammatory Arthritis Centre Versus Arthritis in Glasgow.
- Professor Michael Beresford
EATC4Children - Experimental Arthritis Treatment Centre for Children.
- Dr. Andrew Filer
NIHR Birmingham Biomedical Research Centre.
- Professor Ernest Choy
CREATE - Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre.
- Dr Laura Coates
NIHR Oxford Biomedical Research Centre.
- Professor Andrew Cope
NIHR Guy's and St Thomas' Biomedical Research Centre.
- Dr Francesco Del Galdo
NIHR Leeds Biomedical Research Centre.
- Professor Chris Edwards
NIHR Southampton Biomedical Research Centre.
- Professor John Isaacs
NIHR Newcastle Biomedical Research Centre.
- Professor David Isenberg
NIHR University College London Hospitals Biomedical Research Centre.
- Dr Natasha Jordan
NIHR Cambridge Biomedical Research Centre.
- Professor Iain McInnes
RACE - Research into Inflammatory Arthritis Centre Versus Arthritis.
- Dr Matthew Pickering
NIHR Imperial Biomedical Research Centre.
- Professor Costantino Pitzalis
Centre for Experimental Medicine and Rheumatology.
- Professor Athimalaipet Ramanan
EATC4Children - Experimental Arthritis Treatment Centre for Children and NIHR Bristol Biomedical Research Centre.
- Professor David Walsh
NIHR Nottingham Biomedical Research Centre and Pain Centre Versus Arthritis.
To find out more about the UK MSK TRC and how your company or organisation can collaborate with us. E-mail: email@example.com
Latest news about Musculoskeletal Disorders